Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01864746
Title A Study of Palbociclib in Addition to Standard Endocrine Treatment in Hormone Receptor Positive Her2 Normal Patients With Residual Disease After Neoadjuvant Chemotherapy and Surgery (PENELOPE-B)
Recruitment Active, not recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors German Breast Group
Indications

breast carcinoma

Therapies

Palbociclib

Age Groups: adult | senior
Covered Countries USA | FRA | ESP | DEU | CAN | AUT


No variant requirements are available.